Controlled Trial on Effect of Montelukast Treatment in Children With Obstructive Sleep Apnea Syndrome
Status:
Withdrawn
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Oral therapy with montelukast may lead to improved polysomnographic findings in children with
mild to moderate OSAS with and without allergic rhinitis who a priori require T&A for OSAS.
- A significant proportion of the children with OSAS treated with montelukast will show
reduced severity of OSAS, and this will obviate the need for surgical T&A.